ChatGPT: weekly briefing
25 Oct – 1 Nov 2026
Top stories
- Family sues OpenAI over ChatGPT advice in fatal epilepsy drug taper (Bloomberg Law, 27 Oct) — A family has sued OpenAI in California, alleging ChatGPT gave an epilepsy patient unlicensed advice to taper her anti-seizure medication, leading to her death. The complaint was filed in San Francisco Superior Court.
- Texas sues OpenAI and Sam Altman over ChatGPT safety claims (Insurance Journal, 27 Oct) — Texas Attorney General Ken Paxton has sued OpenAI and Sam Altman, alleging ChatGPT harmed Texans. His office seeks an injunction to block minors' access. OpenAI said it is committed to working with states on industry-wide policy.
- OpenAI tightens weapons information limits for teen ChatGPT users (Reuters, 30 Oct) — OpenAI said it is tightening limits on weapons-related information ChatGPT provides to teenagers as part of a violence-prevention push. Reuters reported the company is also introducing further safeguards for younger users.
- OpenAI cuts funding target by $10bn amid tech stock rout (Business Times, 31 Oct) — The Financial Times reported that OpenAI has cut its latest funding round target by $10bn to about $20bn, with its valuation falling to $1.25tn. The report links the change to an AI-driven sell-off in tech shares.
- Patched ChatGPT share-link flaw could hijack logged-in sessions (AI Weekly, 31 Oct) — Security firm Parameter said a malicious shared ChatGPT link could run code in the session of anyone who opened it, exposing private chats. OpenAI has patched the flaw after escalating its severity rating.
Trends
Scrutiny of OpenAI's products continued this week, with the Texas suit from the previous briefing now reported alongside a coordinated action by eight states, according to Fox23. The safety theme has also widened from child safety into medical advice, through a California wrongful-death suit, and into teen-specific rules on weapons information. OpenAI's patch of a share-link flaw that exposed private chats fits the same pattern of safeguards being tested and tightened. The funding target cut reported by the Financial Times stands apart as commercial news, driven by an AI-related tech sell-off rather than by regulators. The usage-quota changes reported this week are also largely a commercial matter, rather than part of the legal or safety story.
What it means (opinion)
This is opinion, not reporting. The week's stories suggest that the pressure on OpenAI is shifting from general concern to specific legal and product claims, covering medical advice, minors and security. Whether that pressure translates into lasting limits will depend on how the Texas and multistate suits develop, and on whether courts accept claims that chatbot guidance caused harm. Watch for any response from OpenAI to the epilepsy complaint, and for whether other regulators follow the states. The funding picture is the other variable. A smaller round at a lower valuation, reported by the Financial Times, may give investors and regulators more leverage over how fast product changes are made. Next week, the key signals are court filings, further teen-safety details from OpenAI, and whether the funding round closes.
AI-assisted summary of public reporting; the analysis is opinion. Sources are linked above.